Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease
Recent advances in our understanding of cardiovascular disease have revealed that
atherothrombotic events, such as myocardial infarction and ischemic stroke, are the end …
atherothrombotic events, such as myocardial infarction and ischemic stroke, are the end …
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
JB Muhlestein - Thrombosis and haemostasis, 2010 - thieme-connect.com
Inflammation is central to the pathogenesis and progression of atherosclerosis and
thrombosis, the underlying cause of major cardiovascular disease. Platelets, in addition to …
thrombosis, the underlying cause of major cardiovascular disease. Platelets, in addition to …
Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD
KAL Müller, M Chatterjee, D Rath… - Thrombosis and …, 2015 - thieme-connect.com
Platelets play a pivotal role in chronic inflammation leading to progression of atherosclerosis
and acute coronary events. Recent discoveries on novel mechanisms and platelet …
and acute coronary events. Recent discoveries on novel mechanisms and platelet …
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting
A clopidogrel loading dose administered during stenting attenuates inflammation marker
release. However, less is known of the anti-inflammatory effect of clopidogrel maintenance …
release. However, less is known of the anti-inflammatory effect of clopidogrel maintenance …
The ELAPSE (evaluation of long-term clopidogrel antiplatelet and systemic anti-inflammatory effects) study
J Saw, EH Madsen, S Chan, E Maurer-Spurej - Journal of the American …, 2008 - jacc.org
Objectives: This study was designed to evaluate the effects of long-term clopidogrel and
aspirin administration on platelet aggregation, activation, and inflammation. Background …
aspirin administration on platelet aggregation, activation, and inflammation. Background …
Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents
Platelets are central to inflammation-related manifestations of cardiovascular diseases
(CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A 2 …
(CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A 2 …
The role of inflammation in atherothrombosis: current and future strategies of medical treatment
T Geisler, DL Bhatt - Medical Science Monitor, 2004 - medscimonit.com
Atherosclerosis is a pathological process caused by vascular remodeling. It symbolizes one
of the major causes for morbidity and mortality in the western world. The causes for these …
of the major causes for morbidity and mortality in the western world. The causes for these …
Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention
MJ Quinn, DL Bhatt, F Zidar, D Vivekananthan… - The American journal of …, 2004 - Elsevier
Platelets play an important role in the inflammatory response. In a nonrandomized
comparison, we examined the effect of clopidogrel pretreatment on platelet inflammatory …
comparison, we examined the effect of clopidogrel pretreatment on platelet inflammatory …
The role of inflammation in atherothrombosis: implications for clinical practice
A Tedgui - Vascular medicine, 2005 - journals.sagepub.com
Inflammation plays a key role in atherothrombosis: in the development of plaques, plaque
rupture and thrombus formation. Various biochemical substances have been shown to be …
rupture and thrombus formation. Various biochemical substances have been shown to be …
Platelet function in clopidogrel-treated patients with acute coronary syndrome
D Sibbing, O von Beckerath, A Schömig… - Blood coagulation & …, 2007 - journals.lww.com
Percutaneous coronary intervention (PCI) in patients presenting with acute coronary
syndrome (ACS) is associated with increased risk of thrombotic complications. ACS …
syndrome (ACS) is associated with increased risk of thrombotic complications. ACS …
相关搜索
- clinical evidence atherothrombotic disease
- antiplatelet therapy atherothrombotic patients
- antiplatelet therapy clinical evidence
- inflammatory markers atherothrombotic patients
- antiplatelet therapy inflammatory markers
- inflammatory markers effects of clopidogrel
- platelet function inflammation in patients
- platelet activation antiplatelet agents
- heart disease effects of clopidogrel
- inflammatory markers heart disease
- antiplatelet therapy atherothrombotic disease
- inflammatory markers difference in the effects
- heart disease difference in the effects